Roopa Industries Share Price Today | Stock Price & Roopa Industries Share Screener
As of October 5, 2026, the live Roopa Industries share price (BSE: ROOPAIND) is ₹51.17, up 9.10% from the previous close, with shares trading between ₹44.70 and ₹55.00 in today's trading session, and a 52-week range of ₹39.19–₹60.48. Check ROOPAIND 52-week high low for the annual price range and momentum. Use the Roopa Industries stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Roopa Industries opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Roopa Industries Share Price Chart
Track the current stock price of Roopa Industries with an interactive chart. Analyse ROOPAIND share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Roopa Industries stock quote in one place.
The quote of ₹51.17 sits between the 52-week low of ₹39.19 and the 52-week high of ₹60.48, and the latest session moved 9.10% from the previous close.
Roopa Industries Company Profile - Fundamental Screener
Screen Roopa Industries company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ROOPAIND shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE443C01010.
Company Details
Classification
Identifiers and Leadership
Roopa Industries Balance Sheet Screener
Screen ROOPAIND balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹72, down from ₹77 in 2025.
Latest statistics put total assets at ₹72 and shareholder funds at ₹18, with a leverage ratio of 1.83.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 72 | 77 | 65 | 57 | 49 | 46 | 38 | 37 | 35 | 29 |
| Current Assets | 63 | 67 | 49 | 42 | 38 | 36 | 27 | 25 | 26 | 22 |
| Fixed Assets | 8 | 8 | 9 | 10 | 10 | 10 | 11 | 6 | 6 | 7 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 4 | 8 | 7 | 3 | 5 | 9 | 9 | 10 | 11 | 8 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 18 | 18 | 16 | 14 | 13 | 12 | 11 | 10 | 10 | 9 |
| Share Capital | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves & Surplus | 10 | 10 | 8 | 6 | 5 | 4 | 3 | 3 | 2 | 2 |
Roopa Industries Income Statement Screener - Profit & Revenue Analysis
Screen Roopa Industries income statement and profit fundamentals. Analyze ROOPAIND quarterly results. Roopa Industries reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹126 and net profit was ₹0, equal to earnings per unit of ₹0.20, at an operating margin of 3%.
In that period expenses were ₹122, interest cost ₹3 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹128 and net profit of ₹0.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||
| Revenue | 126 | 128 | 123 | 72 | 77 | 51 | 29 | 29 | 30 | 24 | 30 | 34 | 31 |
| Expenses | 122 | 119 | 117 | 66 | 72 | 48 | 26 | 26 | 28 | 22 | 28 | 32 | 29 |
Operating Costs and Margins | |||||||||||||
| EBITDA | 4 | 8 | 6 | 6 | 5 | 4 | 3 | 3 | 3 | 2 | 3 | 2 | 2 |
| Operating Profit % | 3.00% | 6.00% | 3.00% | 6.00% | 5.00% | 7.00% | 9.00% | 6.00% | 8.00% | -14.00% | 7.00% | -3.00% | 7.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 3 | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 |
Profit and Earnings | |||||||||||||
| Profit Before Tax | 0 | 0 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 2 | 2 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
| EPS | 0.20 | 0.13 | 2.57 | 1.95 | 1.72 | 1.30 | 0.98 | 0.48 | 0.77 | 0.69 | 0.00 | 0.22 | 0.20 |
Roopa Industries Cash Flow Screener - Liquidity Fundamentals
Screen ROOPAIND cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹5, and net cash flow was an outflow of ₹3.
Over the same period, investing activities used ₹1 and financing activities used ₹8.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 5 | -7 | 2 | 0 | 2 | -1 | 2 | 4 | -5 | -1 |
| Investing Activities | -1 | 2 | 1 | -1 | 4 | 1 | 1 | -2 | 3 | 0 |
Financing and Net Cash | ||||||||||
| Financing Activities | -8 | 5 | -2 | 2 | -5 | -1 | -3 | -2 | 2 | 2 |
| Net Cash Flow | -3 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
Roopa Industries Shareholding Pattern Screener
See Roopa Industries shareholding pattern with promoter, FII, and DII holdings. Check Roopa Industries promoter holding and ownership changes for ROOPAIND on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 48.03%, foreign institutions 0.25%, domestic institutions 0.00% and the public 41.00%, spread across 3,954 shareholders.
The shareholder count was 3,954 in 2026-Mar, compared with 3,888 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 48.03% | 48.03% | 48.03% | 48.03% | 48.03% | 48.03% | 48.03% | 48.03% |
Institutional Investors | ||||||||
| FII Holding | 0.25% | 0.25% | 0.25% | 0.25% | 0.25% | 0.25% | 0.25% | 0.25% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 41.00% | 41.00% | 40.85% | 40.95% | 40.87% | 40.92% | 40.63% | 40.67% |
| Other Holding | 10.72% | 10.72% | 10.86% | 10.76% | 10.85% | 10.80% | 11.09% | 11.05% |
| Shareholder Count | 3,954 | 3,888 | 4,007 | 4,002 | 3,982 | 3,952 | 3,622 | 3,616 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Roopa Industries. Roopa Industries dividend yield can be compared with peers and other stocks in the market.
Roopa Industries Stock Index Membership - Nifty & Sensex
See which indices include Roopa Industries stock. Check ROOPAIND index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Roopa Industries Market Events Screener - Corporate Actions
Get Roopa Industries corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Roopa Industries stock events that may affect ROOPAIND share price, along with derivatives, futures and options activity and sector gainers.
11 corporate actions are listed, the most recent entry being Annual General Meeting dated September 30, 2026, with a record date of September 30, 2026.
It is followed by Quarterly Result Announcement dated August 14, 2026 and Quarterly Result Announcement dated May 30, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-30 | 2026-09-30 | Annual General Meeting | NA | -6.25% |
| 2026-08-14 | 2026-08-14 | Quarterly Result Announcement | NA | 1.83% |
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | -4.47% |
| 2026-02-14 | 2026-02-14 | Quarterly Result Announcement | NA | -0.54% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -0.20% |
| 2025-09-30 | 2025-09-30 | Annual General Meeting | NA | -1.87% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | -4.67% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -5.64% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -7.94% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -5.55% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | -1.81% |
Roopa Industries Competitors Screener - Peer Stocks Comparison
Screen ROOPAIND competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 428,425 | 35.84 | 61,674 | 12.69% | 11,565 | 36.68 |
| Divis Laboratories | 243,315 | 84.36 | 11,067 | 13.95% | 2,568 | 51.70 |
| Torrent Pharmaceuticals | 180,743 | 84.01 | 13,886 | 20.34% | 2,138 | 41.12 |
| Zydus Life Science | 113,765 | 24.88 | 27,658 | 17.64% | 5,026 | 47.64 |
| Cipla | 107,930 | 32.42 | 29,045 | 2.24% | 3,870 | 34.78 |
| Laurus Labs | 106,225 | 98.56 | 6,868 | 22.01% | 890 | 58.70 |
| Mankind Pharma | 102,266 | 50.48 | 14,636 | 14.85% | 1,938 | 61.75 |
| Dr Reddys Laboratories | 99,903 | 31.47 | 35,059 | 3.90% | 4,158 | 53.84 |
| Aurobindo Pharma | 96,347 | 25.97 | 34,145 | 5.56% | 3,503 | 50.30 |
| Lupin | 91,956 | 16.71 | 29,039 | 26.75% | 5,356 | 31.59 |
Roopa Industries Company Announcements - News & Reports Screener
Screen ROOPAIND latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 2, 2026.
The next most recent announcements are dated October 1, 2026 and September 26, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-02 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-10-01 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-26 | Closure of Trading Window | - |
| 2026-09-08 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-05 | Reg. 34 (1) Annual Report. | - |
| 2026-09-05 | Intimation Of Annual General Meeting For The FY 2025-26 | - |
| 2026-09-01 | Outcome Of Board Meeting Held On 1St September 2026 | - |
| 2026-08-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-14 | Submission Of Unaudited Financial Results | - |
| 2026-08-14 | Board Meeting Outcome for Submission Of Unaudited Financial Results And Intimation Of Outcome Of The Board Meeting Held On 14Th August 2026 | - |
| 2026-08-11 | Submission Of Report On Re-Lodgement Of Transfer Requests Of Physical Shares Under Special Window | - |
| 2026-08-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-07 | Board Meeting Intimation for Intimation Regarding Board Meeting To Be Held On Friday 14Th August 2026 To Consider And Approve The Unaudited Financial Results For The Quarter Ended On 30Th June 2026 | - |
| 2026-07-23 | Submission Of Report On Re-Lodgement Of Transfer Requests Of Physical Shares Under Special Window | - |
| 2026-07-11 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-25 | Closure of Trading Window | - |
| 2026-06-15 | Submission Of Newspaper Clipping Pursuant To SEBI Circular No. SEBI/HO/38/13/11(2)2026- MIRSD-Pod/1/3750/2026 Dated January 30 2026 | - |
| 2026-06-12 | Submission Of Report On Re-Lodgement Of Transfer Requests Of Physical Shares Under Special Window | - |
| 2026-06-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-30 | Announcement under Regulation 30 (LODR)-Change in Management | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹51.17, within a 52-week range of ₹39.19 to ₹60.48. The P/E ratio is 293.13 and the P/B ratio is 2.10, with earnings per unit of ₹0.13. Market capitalisation stands at ₹39.34 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.